Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE).

被引：0
|
作者：
Hedrick, E.
Kozloff, M.
Hainsworth, J.
Badarinath, S.
Cohn, A.
Flynn, P.
Dong, W.
Suzuki, S.
Sugrue, M.
Grothey, A.
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Florida Oncol Associates, Jacksonville, FL USA
[5] Rocky Mt Canc Ctr, Denver, CO USA
[6] Abbott NW Hosp, Minneapolis, MN 55407 USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3536
引用
收藏
页码：155S / 155S
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRITE)
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Steis, R.
    Dong, W.
    Suzuki, S.
    Sugrue, M.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 128 - 128
  • [2] Safety and efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE)
    Kozloff, M.
    Hainsworth, J.
    Badrinath, S.
    Cohn, A.
    Flynn, P.
    Steis, R.
    Dong, W.
    Suzuki, S.
    Sarkar, S.
    Sugrue, M.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [3] Safety analysis of first-line bevacizumab plus chemotherapy in patients with metastatic colorectal cancer (mCRC) participating in a US registry
    Kozloff, M.
    Cohn, A.
    Christiansen, N.
    Flynn, P.
    Kabbinavar, F.
    Robles, R.
    Ulcickas-Yood, M.
    Sarkar, S.
    Hambleton, J.
    Grothey, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 173 - 173
  • [4] SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: UPDATED RESULTS FROM A LARGE CZECH OBSERVATIONAL REGISTRY
    Prausova, J.
    Gruna, J.
    Twardzikova, P.
    Vyzula, R.
    Benesova, V
    Bartos, J.
    Sejdova, M.
    Petera, J.
    Ostrizkova, L.
    Finek, J.
    ANNALS OF ONCOLOGY, 2009, 20 : 71 - 72
  • [5] Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large community-based observational cohort study in Germany
    Arnold, D.
    Kindler, M.
    Petersen, V.
    Tummes, D.
    Moelle, M.
    Schoeberl, C.
    Srock, S.
    Hinke, A.
    Grothe, W.
    ONKOLOGIE, 2010, 33 : 61 - 61
  • [6] FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM A LARGE GERMAN COMMUNITY-BASED OBSERVATIONAL COHORT STUDY
    Arnold, D.
    Kindler, M.
    Petersen, V
    Tummes, D.
    Molle, M.
    Schoberl, C.
    Srock, S.
    Kutscheidt, A.
    Grothe, W.
    ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [7] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531
  • [8] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
    Van Cutsem, E.
    Berry, S.
    Michael, M.
    Kretzschmar, A.
    Rivera, F.
    DiBartolomeo, M.
    Mazier, M.
    Andre, N.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [9] SINGLE INSTITUTION RESULTS OF FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (MCRC)
    Barkmanova, Jaroslava
    Petruzelka, Lubos
    Sedlackova, Eva
    Vocka, Michal
    Hejduk, Karel
    Bortlicek, Zbynek
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort
    Rouyer, Magali
    Fourrier-Reglat, Annie
    Smith, Denis
    Becouarn, Yves
    Guimbaud, Rosine
    Tubiana-Mathieu, Nicole
    Robinson, Philip
    Jove, Jeremy
    Grelaud, Angela
    Noize, Pernelle
    Moore, Nicholas
    Ravaud, Alain
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (03) : 187 - 194
12345